2022
When Less May Be Enough: Dose Selection Strategies for Immune Checkpoint Inhibitors Focusing on AntiPD-(L)1 Agents
Targeted Oncology
Research at a glance
Research activity
My publications
Filter publications
29 publications
2021
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
Journal for ImmunoTherapy of Cancer
鈥�2021
Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy
JNCI Cancer Spectrum
鈥�2021
Beyond immune checkpoint blockade: emerging immunological strategies
Nature Reviews Drug Discovery
2021
Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics
Cancer Treatment Reviews